MMP-9/NGAL Modulation by Piper Crocatum in Early Diabetic Nephropathy

NACompletedINTERVENTIONAL
Enrollment

387

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

September 5, 2024

Study Completion Date

September 16, 2024

Conditions
Early Renal Dysfunction in DiabetesDiabetic NephropathyInflammation and Oxidative Stress in Diabetic Patients
Interventions
DIETARY_SUPPLEMENT

Piper crocatum Extract Cookie

Participants in the intervention group will receive cookies containing a standardized 10% ethyl acetate extract of Piper crocatum, known for its antioxidant and anti-inflammatory properties. These cookies will be consumed twice daily for 12 weeks. The intervention aims to assess the effects of Piper crocatum on renal biomarkers, such as MMP-9 and NGAL, in diabetic patients with early renal dysfunction

DIETARY_SUPPLEMENT

Placebo Comparator

Participants in the placebo group will receive cookies that are identical in appearance, taste, and texture to the active Piper crocatum cookies but do not contain the Piper crocatum extract. These cookies will be consumed twice daily for 12 weeks, serving as a control to assess the effects of the active intervention on renal biomarkers associated with diabetic nephropathy.

Trial Locations (1)

90245

Public Health Center in Makassar, Indonesia, Makassar

All Listed Sponsors
lead

Hasanuddin University

OTHER

NCT06676124 - MMP-9/NGAL Modulation by Piper Crocatum in Early Diabetic Nephropathy | Biotech Hunter | Biotech Hunter